1. Influence of HLA-A, -B, -DR Polymorphisms on the Severity of COVID-19: A Case-Control Study in the Iranian Population.
- Author
-
Mashayekhi, Parisa, Omrani, Mir Davood, Yassin, Zeynab, Dehghanifard, Ali, Ashouri, Leila, Afjeh, Sara Sadat Aghabozorg, and Shabanzadeh, Zahra
- Subjects
- *
HLA-B27 antigen , *COVID-19 , *GENETIC polymorphisms , *ALLELES , *CASE-control method , *SEVERITY of illness index , *DISEASE susceptibility , *DESCRIPTIVE statistics , *OLIGONUCLEOTIDE arrays - Abstract
Background: As an emerging pandemic disease, COVID-19 encompasses a spectrum of clinical diagnoses, from the common cold to severe respiratory syndrome. Considering the shreds of evidence demonstrating the relationship between human leukocyte antigen (HLA) allele diversity and infectious disease susceptibility, this study was conducted to determine the association of HLA alleles with COVID-19 severity in Iranian subjects. Methods: In this case-control study, a total of 200 unrelated individuals (consisting of 100 people with severe COVID-19 and an average age of 55.54 as the case group, and 100 patients with mild COVID-19 with an average age of 48.97 as the control group) were recruited, and HLA typing (Locus A, B, and DR) was performed using the Olerup sequence-specific oligonucleotide (SSO) HLA-typing kit. Results: Our results showed that HLA-A*11 and HLA-DRB1*14 alleles were more frequently observed in severe COVID-19 cases, while HLA-B*52 was more common in mild cases, which was in agreement with some previous studies. Conclusion: Our results confirmed the evidence for the association of HLA alleles with COVID-19 outcomes. We found that HLA-A*11 and HLA-DRB1*14 alleles may be susceptibility factors for severe COVID-19, while HLA-B*52 may be a protective factor. These findings provide new insight into the pathogenesis of COVID-19 and help patient management. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF